Table 1 Clinical characteristics of the enrolled patients
Total cohort N = 17 | |
|---|---|
Age, years | 65 (56–75) |
Male (%) | 7 (41%) |
APACHE II score | 8 (5–11) |
SOFA score | 3.0 (2.5–3.5) |
Duration of HFNC, hours | 76 (34–186) |
Comorbidity | |
Hypertension | 3 (18%) |
Diabetes mellitus | 3 (18%) |
Chronic heart disease | 3 (18%) |
Laboratory tests | |
White blood cell counts, × 109/L | 5.4 (4.2–7.1) |
Lymphocyte count, × 109/L | 0.7 (0.5–0.9) |
Platelet counts, × 109/L | 154 (121–259) |
Hemoglobin, mg/dL | 128 (118–138) |
Albumin, g/L | 35 (32–38) |
Potassium, mmol/L | 3.9 (3.5–4.2) |
Sodium, mmol/L | 136 (135–138) |
Chlorine, mmol/L | 101 (99–105) |
Creatinine, μmol/L | 60 (53–69) |
Total bilirubin, μmol/L | 11 (10–15) |
C-reactive protein, mg/L | 39 (22–67) |
Procalcitonin, ng/mL | 0.07 (0.06–0.09) |